Novel Treatment for Dry Macular Degeneration (AMD)

woman and child playing together

Dry macular degeneration is a chronic eye condition that typically affects patients 60 years and older. It causes gradual deterioration of the macula, the central part of the retina, which is responsible for sharp and detailed vision. 

Until now, there was no approved treatment for AMD. Retina specialists traditionally have recommended lifestyle modification and supplements for prevention of dry macular degeneration. These include:

  1. Nutrition supplements for patients with moderate dry macular degeneration, called the AREDS 2 vitamins.
  2. Lifestyle changes such as a Mediterranean diet, exercising regularly, quit smoking and wearing UV protective sunglasses.

In February 2023, the FDA approved the first injection for dry macular degeneration. It is called Syfovre (pegcetacoplan). It works by blocking a component of the complement system, part of the immune system that is thought to contribute to the development of geographic atrophy.

Clinical trials have shown that it can reduce the rate of progression of dry macular degeneration when given monthly or every other month.

We are excited to announce that Envision Ophthalmology is a Macular Degeneration Center of Excellence.

Give us a call today to have your dry macular degeneration evaluation.

It is important to remember the effectiveness of these treatments can vary depending on the individual, and it’s vital to work closely with your retina specialist to determine the best treatment plan for your specific needs.

We look forward to serving you!

Skip to content